Jelle Huysentruyt

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 4

Top Topics

Signaling Pathway

Top Venues

Science advances

Proceedings of the National Academy of Sciences of the United States of America

This page only lists publications with an associated author ORCID identifier.

Publications

Peter Tougaard, Mario R Pérez, Wolf Steels, Jelle Huysentruyt, Bruno Verstraeten, Jessica Vetters, Tatyana Divert, Amanda Gonçalves, Ria Roelandt, Nozomi Takahashi, Sophie Janssens, Terkild Brink Buus, Tom Taghon, Georges Leclerq, Peter Vandenabeele
Type 1 immunity enables neonatal thymic ILC1 production. Science advances 10 (3) (2024)
Peter Tougaard, Mario R Pérez, Wolf Steels, Jelle Huysentruyt, Bruno Verstraeten, Jessica Vetters, Tatyana Divert, Amanda Gonçalves, Ria Roelandt, Nozomi Takahashi, Sophie Janssens, Terkild Brink Buus, Tom Taghon, Georges Leclerq, Peter Vandenabeele
Type 1 immunity enables neonatal thymic ILC1 production. Science advances 10 (3) (2024)
Peter Tougaard, Mario R Pérez, Wolf Steels, Jelle Huysentruyt, Bruno Verstraeten, Jessica Vetters, Tatyana Divert, Amanda Gonçalves, Ria Roelandt, Nozomi Takahashi, Sophie Janssens, Terkild Brink Buus, Tom Taghon, Georges Leclerq, Peter Vandenabeele
Type 1 immunity enables neonatal thymic ILC1 production. Science advances 10 (3) (2024)
Farzaneh Ghazavi, Jelle Huysentruyt, Jordy De Coninck, Stephanie Kourula, Sofie Martens, Behrouz Hassannia, Tim Wartewig, Tatyana Divert, Ria Roelandt, Bastian Popper, Andreas Hiergeist, Peter Tougaard, Tom Vanden Berghe, Marie Joossens, Geert Berx, Nozomi Takahashi, Adam Wahida, Peter Vandenabeele
Executioner caspases 3 and 7 are dispensable for intestinal epithelium turnover and homeostasis at steady state. Proceedings of the National Academy of Sciences of the United States of America 119 (6) (2022)